Looking forward to taking part in this great event organized by @asco IMG CoP. The J1 waiver is not straightforward and we have excellent expert participants this week including colleagues from Nachman Phulwani Zimovcak (NPZ) Law Group, P.C. and several including myself who come through the process!

Excited to participate in the Johns Hopkins Science Diplomacy Summit 2024 happening on April 15-16, at the Johns Hopkins University Bloomberg Center.
 
We will delve into how #science can foster #internationalcooperation Dr. Catharine Young Giusi Condorelli

Explore the impact of drug and alcohol use on cancer immunotherapy during National Drug and Alcohol Facts Week in our latest blog, featuring CRI Clinical Innovator Dr. Marina Baretti of Johns Hopkins Medicine. Discover: bit.ly/3vcCuZu #NDAFW #CancerResearch #Immunotherapy

Johns Hopkins Medicine Sibley Hospital JHM Integrity CE, LLC Ashwani Rajput Johns Hopkins Kimmel Cancer Center Johns Hopkins Kimmel Cancer Center
Johns Hopkins Medicine
Integrity CE, LLC

👍We had an amazing panel of experts, led by Dr. Mark Yarchoan Mark Yarchoan alone with Marina Baretti Kelly Lafaro Freddy E Escorcia (@freddyeescorcia elsewhere) and David Hsieh discussing treatment options in #HCC

Sexism is not only bad for women, it is bad for science.

rdcu.be/dueZP

Last chance to register for tonights webinar! 'Advanced Treatments in Liver Cancer' Join surgical oncologist
Kelly Lafaro and medical oncologist Marina Baretti
to discuss advanced surgical options and medical management of (HCC) and cholangiocarcinoma.

hopkinsmedicine.org/health/health-…

Join us December 5th at 5:30 for 'Advanced Treatments in Liver Cancer' Join surgical oncologist Kelly Lafaro and medical oncologist Marina Baretti to discuss advanced surgical options and medical management of (HCC) and cholangiocarcinoma.

hopkinsmedicine.org/health/health-…

The mitigation and management of toxicities is a key component of treating patients with biliary tract cancers with targeted therapies. Marina Baretti Johns Hopkins Medicine @gotoper #gotoPER #CFS #oncology onclive.com/view/unique-mo…

The heterogeneity of biliary tract cancers necessitates molecular profiling for all patients, and there is continued focus on developing therapies for therapeutic targets. Marina Baretti Johns Hopkins Medicine @gotoper #gotoPER #CFS #oncology onclive.com/view/unique-mo…

WATCH: Marina Baretti, Johns Hopkins Medicine, discusses the evolving utility of FGFR inhibitors in the treatment of pts with unresectable, advanced, or metastatic intrahepatic FGFR2+ cholangiocarcinoma. onclive.com/view/dr-barett…

Thank you Evelina Santa for the opportunity to be a part of this amazing International Science Forum on “President Biden's Cancer moonshot initiative – state of the art and new perspectives” . linkedin.com/posts/marina-b…

linkedin.com/posts/women-in…

Thank you to @marinabarreti from Sidney Kimmel Cancer Center – Jefferson Health, Matthew Porembka from @UTSWNews, and kathy crow for an insightful discussion on how to deliver multi-d care for liver cancer #SALCS23

Diplomacy for science at JH. It was a great pleasure to host an incredible distinguished group of diplomats from the Italian, German and French Embassies to discuss the use of diplomatic action to facilitate international collaboration @hopkinsmedicine Italy in US Giusi Condorelli

fibrofoundation.org/fcf-funds-plan…
Thank you FCF for your support! Mark Furth Marina Baretti Dr. Elizabeth Jaffee

Honoring Dr. Ross Donehower, program director of HopkinsHemOncFellowship for 30+ year, amazing mentor and master educator. Undoubtedly one of the greatest role model of all time #ASCO2023

Elizabeth M. Jaffee, MD, FAACR, receives the AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research at the #AACR23 Opening Ceremony. Dr. Elizabeth Jaffee

Check our new paper: Visa Constraints and Career Choices for Oncologists Journal of the @NCCN Farah Mazahreh Ahmad Al-Hader
#MedTwitter #OncoTwitter #AcademicTwitter
Thankful for Journal of the National Comprehensive Cancer Network for allowing us to publish this🧵

➡️ jnccn.org/view/journals/…

Many thanks 🙏🏼 to Cholangiocarcinoma Foundation and our outstanding multiD speakers and panelists 🔪 💊 ☢️ 🧬 in the combined #Cholangiocarcinoma Symposium at #AHPBA2023 AHPBA IHPBA Melinda Bachini Marina Baretti Lorraine Portelance Raj Narayanan #ParissaTabrizian #ShishirMaithel

The one and only Mark Yarchoan discussing the role of neoadjuvant Immunotherapy in HCC at @HccTagConf